PTEN and melanoma: As mentioned above, PI3KCA mutations are rare in melanomas, while the loss of PTEN function (as a consequence of mutations, loss of heterozygosity, chromosomal loss, microRNA-dependent repression of PTEN synthesis, and transcriptional silencing induced by methylation) is frequent in melanoma.